GlassScriptPhysician profile
Vicky Morton Bryan
NPI 1265954788
$1,604.90
in general payments reported to CMS, 2019-2025
25 companies · $400 in 2025
The $400 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $151 · 2022: $254 · 2023: $218 · 2024: $581 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,199.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $343.33 | 2024-2025 | |
| W. L. Gore & Associates, INC. | $176.93 | 2024 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Smith+Nephew, INC. | $125.10 | 2022-2024 | Grafix, Grafix Pl, Stravix |
| Solventum Corporation | $103.34 | 2025 | Activ.A.C., V.A.C. Veraflo, Prevena |
| Novo Nordisk INC | $91.73 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $85.42 | 2023-2024 | Xarelto |
| Convatec INC. | $82.67 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $77.20 | 2021-2022 | |
| Lilly USA, LLC | $69.00 | 2021-2022 | |
| Medtronic, INC. | $59.79 | 2022-2023 | Venaseal |
| Kerecis Limited | $57.57 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Organogenesis INC. | $53.05 | 2024-2025 | Via Matrix, Puraply Franchise |
| Pfizer INC. | $47.97 | 2022-2025 | |
| Getinge USA Sales, LLC | $31.41 | 2022 | |
| Atricure, INC. | $25.08 | 2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $21.87 | 2025 | Vistaseal, Surgicel Nu-Knit, Evarrest |
| Abbott Laboratories | $21.70 | 2025 | Freestyle Libre 3 |
| Cardiva Medical, INC. | $20.48 | 2024 | Cardiva Vascade 6/7f Vcs |
| Incyte Corporation | $19.20 | 2025 | Niktimvo |
| Silk Road Medical, INC. | $16.65 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Urgo Medical North America, LLC | $16.08 | 2023 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Glaxosmithkline, LLC. | $15.90 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.48 | 2023 | Seglentis |
| Mimedx Group, INC. | $14.94 | 2024 | |
| Endologix LLC | $13.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vicky Bryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.